{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T07:19:21Z","timestamp":1760080761898,"version":"3.37.3"},"reference-count":47,"publisher":"BMJ","issue":"Suppl 1","license":[{"start":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T00:00:00Z","timestamp":1668124800000},"content-version":"unspecified","delay-in-days":10,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Patient-Centered Outcomes Research Trust Fund","award":["Interagency Agreement #750119PE060048"],"award-info":[{"award-number":["Interagency Agreement #750119PE060048"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Surg Interv Health Technologies"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec><jats:title>Objectives<\/jats:title><jats:p>The accumulation of data through a prospective, multicenter Coordinated Registry Network (CRN) could be a robust and cost-effective way to gather real-world evidence on the performance of pelvic organ prolapse (POP) technologies for device-based and intervention-based studies. To develop the CRN, a group of POP experts consisting of representatives from professional societies, the Food and Drug Administration, academia, industry, and the patient community, was convened to discuss the role and feasibility of the CRN and to identify the core data elements important to assess POP technologies.<\/jats:p><\/jats:sec><jats:sec><jats:title>Design<\/jats:title><jats:p>A Delphi method approach was employed to achieve consensus on a core minimum dataset for the CRN. A series of surveys were sent to the panel and answered by each expert anonymously and individually. Results from the surveys were collected, collated, and analyzed by the study design team from Weill Cornell Medicine. Questions for the next round were based on the analysis process and discussed with group members via conference call. This process was repeated twice over a 6-month time period during which consensus was achieved.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twenty-one experts participated in the effort and proposed 120 data elements. Participation rates in the first and second round of the Delphi survey were 95.2% and 71.4%, respectively. The working group reached final consensus among responders on 90 data elements capturing relevant general medical and surgical history, procedure and discharge, short-term and long-term follow-up, device factors, and surgery and surgeon factors.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>The CRN successfully developed a set of core data elements to support the study of POP technologies through convening an expert panel on POP technologies and using the Delphi method. These standardized data elements have the potential to influence patient and provider decisions about treatments and include important outcomes related to efficacy and safety.<\/jats:p><\/jats:sec>","DOI":"10.1136\/bmjsit-2020-000076","type":"journal-article","created":{"date-parts":[[2022,11,14]],"date-time":"2022-11-14T17:01:33Z","timestamp":1668445293000},"page":"e000076","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Development of a coordinated registry network for pelvic organ prolapse technologies"],"prefix":"10.1136","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2841-9183","authenticated-orcid":false,"given":"Courtney E","family":"Baird","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bilal","family":"Chughtai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine S","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Kobashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3882-9765","authenticated-orcid":false,"given":"Art","family":"Sedrakyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharon","family":"Andrews","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Ferriter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terri","family":"Cornelison","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danica","family":"Marinac-Dabic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2022,11,14]]},"reference":[{"key":"2022111409003172000_4.Suppl_1.e000076.1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181898ba9"},{"key":"2022111409003172000_4.Suppl_1.e000076.2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1471-0528.2008.02023.x","article-title":"Efficacy and safety of transvaginal mesh kits in the treatment of prolapse of the vaginal apex: a systematic review","volume":"116","author":"Feiner","year":"2009","journal-title":"BJOG"},{"key":"2022111409003172000_4.Suppl_1.e000076.3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1009521"},{"key":"2022111409003172000_4.Suppl_1.e000076.4","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s00192-014-2333-x","article-title":"Vaginal prolapse surgery with transvaginal mesh: results of the Austrian registry","volume":"25","author":"Bjelic-Radisic","year":"2014","journal-title":"Int Urogynecol J"},{"key":"2022111409003172000_4.Suppl_1.e000076.5","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1007\/s00192-011-1542-9","article-title":"Surgical management of pelvic organ prolapse in women: the updated summary version cochrane review","volume":"22","author":"Maher","year":"2011","journal-title":"Int Urogynecol J"},{"key":"2022111409003172000_4.Suppl_1.e000076.6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.h2685"},{"key":"2022111409003172000_4.Suppl_1.e000076.7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1001\/jamasurg.2016.4200","article-title":"Association between the amount of vaginal mesh used with mesh erosions and repeated surgery after repairing pelvic organ prolapse and stress urinary incontinence","volume":"152","author":"Chughtai","year":"2017","journal-title":"JAMA Surg"},{"key":"2022111409003172000_4.Suppl_1.e000076.8","doi-asserted-by":"crossref","first-page":"495.e1","DOI":"10.1016\/j.ajog.2016.12.021","article-title":"Is vaginal mesh a stimulus of autoimmune disease?","volume":"216","author":"Chughtai","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"2022111409003172000_4.Suppl_1.e000076.9","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1016\/j.juro.2017.04.099","article-title":"Challenging the myth: transvaginal mesh is not associated with carcinogenesis","volume":"198","author":"Chughtai","year":"2017","journal-title":"J Urol"},{"key":"2022111409003172000_4.Suppl_1.e000076.10","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1007\/s00192-016-3244-9","article-title":"Role of concurrent vaginal hysterectomy in the outcomes of mesh-based vaginal pelvic organ prolapse surgery","volume":"28","author":"Forde","year":"2017","journal-title":"Int Urogynecol J"},{"key":"2022111409003172000_4.Suppl_1.e000076.11","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000003689"},{"key":"2022111409003172000_4.Suppl_1.e000076.12"},{"key":"2022111409003172000_4.Suppl_1.e000076.13","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)32572-7"},{"key":"2022111409003172000_4.Suppl_1.e000076.14","unstructured":"U.S. Food and Drug Administration . Urogynecologic surgical mesh: update on the safety and effectiveness of transvaginal placement for pelvic organ prolapse. Silver Spring, MD, 2011."},{"key":"2022111409003172000_4.Suppl_1.e000076.15","doi-asserted-by":"publisher","DOI":"10.1097\/SPV.0000000000000433"},{"key":"2022111409003172000_4.Suppl_1.e000076.16","unstructured":"U.S. Food and Drug Administration . Fda strengthens requirements for surgical mesh for the transvaginal repair of pelvic organ prolapse to address safety risks. Silver Spring, MD, 2016."},{"key":"2022111409003172000_4.Suppl_1.e000076.17","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017125"},{"key":"2022111409003172000_4.Suppl_1.e000076.18","unstructured":"U.S. Food and Drug Administration . FDA\u2019s activities: urogynecologic surgical mesh. Silver Spring, MD, 2019. https:\/\/www.fda.gov\/medical-devices\/urogynecologic-surgical-mesh-implants\/fdas-activities-urogynecologic-surgical-mesh#:~:text=On%20July%2013%2C%202018%2C%20the,their%20product%20from%20the%20market"},{"key":"2022111409003172000_4.Suppl_1.e000076.19","unstructured":"U.S. Food and Drug Administration . FDA takes action to protect women\u2019s health, orders manufacturers of surgical mesh intended for transvaginal repair of pelvic organ prolapse to stop selling all devices. Silver Spring, MD, 2019. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-takes-action-protect-womens-health-orders-manufacturers-surgical-mesh-intended-transvaginal"},{"key":"2022111409003172000_4.Suppl_1.e000076.20","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.11036"},{"key":"2022111409003172000_4.Suppl_1.e000076.21","unstructured":"Brown BB . Delphi process: a methodology used for the elicitation of opinions of experts. Santa Monica, CA: RAND Corporation, 1968."},{"key":"2022111409003172000_4.Suppl_1.e000076.22","first-page":"10","article-title":"The Delphi technique: making sense of consensus","volume":"12","author":"Hsu","year":"2007","journal-title":"Practical Assessment, Research, and Evaluation"},{"key":"2022111409003172000_4.Suppl_1.e000076.23","first-page":"4","article-title":"Using experts' opinions through Delphi technique","volume":"12","author":"Yousuf","year":"2007","journal-title":"Practical Assessment, Research, and Evaluation"},{"key":"2022111409003172000_4.Suppl_1.e000076.24","unstructured":"Marinac-Dabic D , Aryal S , Azarbaijani Y , et al . The Women\u2019s Health Technologies Coordinated Registry Network (WHT-CRN). U.S. Food and Drug Administration, 2020. https:\/\/9a8ad4b9-d27b-46ff-9aa0-f3457074f526.filesusr.com\/ugd\/361e0e_bf040bd8f23b48a182394b0d6ce9eb04.pdf"},{"key":"2022111409003172000_4.Suppl_1.e000076.25","doi-asserted-by":"crossref","unstructured":"Sedrakyan A , Pappas G , Drozda J , et al . Advancing the real-world evidence for medical devices through coordinated registry networks. BMJ Surg Interv Health Technologies 2022;4:e000123.doi:10.1136\/bmjsit-2021-000123","DOI":"10.1136\/bmjsit-2021-000123"},{"key":"2022111409003172000_4.Suppl_1.e000076.26","doi-asserted-by":"crossref","unstructured":"Baird CE , Marinac-Dabic D , Sedrakyan A . Building blocks for long-acting and permanent contraceptives coordinated registry network. BMJ Surg Interv Health Technologies 2022;4:e000075.doi:10.1136\/bmjsit-2020-000075","DOI":"10.1136\/bmjsit-2020-000075"},{"key":"2022111409003172000_4.Suppl_1.e000076.27","doi-asserted-by":"crossref","unstructured":"Baird CE , Marinac-Dabic D , Sedrakyan A , et al . Development of a core minimum dataset to advance real-world evidence generation for uterine fibroids treatment technologies. BMJ Surg Interv Health Technologies 2022;4:e000094.doi:10.1136\/bmjsit-2021-000094","DOI":"10.1136\/bmjsit-2021-000094"},{"key":"2022111409003172000_4.Suppl_1.e000076.28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.ejvs.2018.04.006","article-title":"International Consortium of vascular registries consensus recommendations for peripheral revascularisation registry data collection","volume":"56","author":"Behrendt","year":"2018","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2022111409003172000_4.Suppl_1.e000076.29","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1016\/j.juro.2017.12.058","article-title":"Development of a nationally representative coordinated registry network for prostate ablation technologies","volume":"199","author":"Golan","year":"2018","journal-title":"J Urol"},{"key":"2022111409003172000_4.Suppl_1.e000076.30","unstructured":"Duke Clinical Research Institute . Registry data standards Durham, NC, 2020. Available: https:\/\/dcri.org\/registry-data-standards\/ [Accessed 30 Jul 2020]."},{"key":"2022111409003172000_4.Suppl_1.e000076.31","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/anae.14569","article-title":"A review of ASA physical status - historical perspectives and modern developments","volume":"74","author":"Mayhew","year":"2019","journal-title":"Anaesthesia"},{"key":"2022111409003172000_4.Suppl_1.e000076.32","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1097\/01.AOG.0000180183.03897.72","article-title":"Vaginal wall descensus and pelvic floor symptoms in older women","volume":"106","author":"Bradley","year":"2005","journal-title":"Obstet Gynecol"},{"key":"2022111409003172000_4.Suppl_1.e000076.33","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e31816a3b96"},{"key":"2022111409003172000_4.Suppl_1.e000076.34","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181b2b1ae"},{"key":"2022111409003172000_4.Suppl_1.e000076.35","doi-asserted-by":"crossref","first-page":"601.e1","DOI":"10.1016\/j.ajog.2016.06.022","article-title":"Recurrence of vaginal prolapse after total vaginal hysterectomy with concurrent vaginal uterosacral ligament\u00a0suspension: comparison between normal-weight\u00a0and overweight women","volume":"215","author":"Rappa","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"2022111409003172000_4.Suppl_1.e000076.36","first-page":"75","article-title":"Pelvic Organ Prolapse Quantification System (POP-Q) - a new era in pelvic prolapse staging","volume":"4","author":"Persu","year":"2011","journal-title":"J Med Life"},{"key":"2022111409003172000_4.Suppl_1.e000076.37","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000133083.54934.ae"},{"key":"2022111409003172000_4.Suppl_1.e000076.38","unstructured":"U.S. Food and Drug Administration . Unique device identification system (UDI system) silver spring, MD, 2020. Available: https:\/\/www.fda.gov\/medical-devices\/device-advice-comprehensive-regulatory-assistance\/unique-device-identification-system-udi-system [Accessed 30 Jul 2020]."},{"key":"2022111409003172000_4.Suppl_1.e000076.39","unstructured":"U.S. Food and Drug Administration . Unique device identification. Silver Spring, MD, 2019."},{"key":"2022111409003172000_4.Suppl_1.e000076.40","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1001\/jamasurg.2015.2590","article-title":"Removal or revision of vaginal mesh used for the treatment of stress urinary incontinence","volume":"150","author":"Welk","year":"2015","journal-title":"JAMA Surg"},{"key":"2022111409003172000_4.Suppl_1.e000076.41","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0b013e3181d991c4"},{"key":"2022111409003172000_4.Suppl_1.e000076.42","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181b2b1ae"},{"key":"2022111409003172000_4.Suppl_1.e000076.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.12.025"},{"key":"2022111409003172000_4.Suppl_1.e000076.44","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-003-1063-2"},{"key":"2022111409003172000_4.Suppl_1.e000076.45","doi-asserted-by":"publisher","DOI":"10.1002\/nau.20041"},{"key":"2022111409003172000_4.Suppl_1.e000076.46","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00192-009-1069-5","article-title":"Validation of the patient global impression of improvement (PGI-I) for urogenital prolapse","volume":"21","author":"Srikrishna","year":"2010","journal-title":"Int Urogynecol J"},{"key":"2022111409003172000_4.Suppl_1.e000076.47","doi-asserted-by":"publisher","DOI":"10.1007\/s11136-009-9496-9"}],"container-title":["BMJ Surgery, Interventions, &amp; Health Technologies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjsit-2020-000076","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,12]],"date-time":"2023-03-12T01:20:44Z","timestamp":1678584044000},"score":1,"resource":{"primary":{"URL":"https:\/\/sit.bmj.com\/lookup\/doi\/10.1136\/bmjsit-2020-000076"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":47,"journal-issue":{"issue":"Suppl 1","published-online":{"date-parts":[[2022,11,14]]},"published-print":{"date-parts":[[2022,11]]}},"alternative-id":["10.1136\/bmjsit-2020-000076"],"URL":"https:\/\/doi.org\/10.1136\/bmjsit-2020-000076","relation":{},"ISSN":["2631-4940"],"issn-type":[{"type":"electronic","value":"2631-4940"}],"subject":[],"published":{"date-parts":[[2022,11]]}}}